Dicerna Pharmaceuticals
Signal active
Organization
Contact Information
Overview
Dicerna Pharmaceuticals is a biotechnology company involved in the discovery and development of innovative treatments for rare inherited diseases affecting the liver, along with cancers, and other therapeutic areas to address liver problems. It is using ribonucleic acid interference (RNA) technology platform to develop its products. The product candidates are DCR-PHXC (for primary hyperoxaluria), DCR-undisclosed (for orphan genetic disease), DCR-PCSK9 (for cardiovascular disease), and DCR-HBV (for hepatitis B virus) among others.
The company was founded in 2007 and is headquartered in Lexington, Massachusetts.
About
Industries
Biotechnology, Health Care, Pharmaceutical, Genetics
Founded
2007
Employees
251-500
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Dicerna Pharmaceuticals headquartered in United States, North America, operates in the Biotechnology, Health Care, Pharmaceutical, Genetics sector. The company focuses on Biotechnology and has secured $53.8B in funding across 128 round(s). With a team of 251-500 employees, Dicerna Pharmaceuticals is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Dicerna Pharmaceuticals, raised $4.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
8
Investors
2
Lead Investors
0
Total Funding Amount
$420.5M
Details
4
Dicerna Pharmaceuticals has raised a total of $420.5M in funding over 4 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2008 | Early Stage Venture | 8.4M | ||
| 2010 | Early Stage Venture | 29.1M | ||
| 2013 | Late Stage Venture | 60.0M | ||
| 2010 | Early Stage Venture | 4.0M |
Investors
Dicerna Pharmaceuticals is funded by 22 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Dicerna Pharmaceuticals | - | FUNDING ROUND - Dicerna Pharmaceuticals | 8.4M |
| Skyline Ventures | - | FUNDING ROUND - Skyline Ventures | 8.4M |
| Dicerna Pharmaceuticals | - | FUNDING ROUND - Dicerna Pharmaceuticals | 60.0M |
| Deerfield | - | FUNDING ROUND - Deerfield | 60.0M |
Recent Activity
There is no recent news or activity for this profile.